vs

Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Kinetik Holdings Inc. (KNTK). Click either name above to swap in a different company.

Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $410.0M, roughly 2.0× Kinetik Holdings Inc.). On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (7.5% vs -7.5%). Over the past eight quarters, Kinetik Holdings Inc.'s revenue compounded faster (6.8% CAGR vs 2.0%).

Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.

Kinetik Holdings Inc. is a midstream energy infrastructure provider primarily focused on the Permian Basin region. It delivers integrated solutions including natural gas gathering, processing, transportation and storage, as well as crude oil and produced water handling services for upstream oil and gas operators across major energy production areas in the southern United States.

ACHC vs KNTK — Head-to-Head

Bigger by revenue
ACHC
ACHC
2.0× larger
ACHC
$829.0M
$410.0M
KNTK
Growing faster (revenue YoY)
ACHC
ACHC
+15.0% gap
ACHC
7.5%
-7.5%
KNTK
Faster 2-yr revenue CAGR
KNTK
KNTK
Annualised
KNTK
6.8%
2.0%
ACHC

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ACHC
ACHC
KNTK
KNTK
Revenue
$829.0M
$410.0M
Net Profit
$4.5M
Gross Margin
Operating Margin
Net Margin
0.5%
Revenue YoY
7.5%
-7.5%
Net Profit YoY
-50.8%
EPS (diluted)
$0.05
$-0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACHC
ACHC
KNTK
KNTK
Q1 26
$829.0M
$410.0M
Q4 25
$821.5M
$430.4M
Q3 25
$851.6M
$464.0M
Q2 25
$869.2M
$426.7M
Q1 25
$770.5M
$443.3M
Q4 24
$774.2M
$385.7M
Q3 24
$815.6M
$396.4M
Q2 24
$796.0M
$359.5M
Net Profit
ACHC
ACHC
KNTK
KNTK
Q1 26
$4.5M
Q4 25
$-1.2B
$416.7M
Q3 25
$36.2M
$5.3M
Q2 25
$30.1M
$23.6M
Q1 25
$8.4M
$19.3M
Q4 24
$32.6M
$16.2M
Q3 24
$68.1M
$25.8M
Q2 24
$78.5M
$37.2M
Operating Margin
ACHC
ACHC
KNTK
KNTK
Q1 26
Q4 25
-142.4%
11.2%
Q3 25
4.7%
4.3%
Q2 25
5.8%
18.2%
Q1 25
1.7%
4.3%
Q4 24
4.9%
6.1%
Q3 24
12.1%
18.4%
Q2 24
13.4%
15.7%
Net Margin
ACHC
ACHC
KNTK
KNTK
Q1 26
0.5%
Q4 25
-143.3%
96.8%
Q3 25
4.3%
1.1%
Q2 25
3.5%
5.5%
Q1 25
1.1%
4.3%
Q4 24
4.2%
4.2%
Q3 24
8.4%
6.5%
Q2 24
9.9%
10.3%
EPS (diluted)
ACHC
ACHC
KNTK
KNTK
Q1 26
$0.05
$-0.07
Q4 25
$-12.98
$2.22
Q3 25
$0.40
$0.03
Q2 25
$0.33
$0.33
Q1 25
$0.09
$0.05
Q4 24
$0.36
$0.01
Q3 24
$0.74
$0.35
Q2 24
$0.85
$0.54

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACHC
ACHC
KNTK
KNTK
Cash + ST InvestmentsLiquidity on hand
$158.5M
Total DebtLower is stronger
$2.5B
$187.1M
Stockholders' EquityBook value
$2.0B
Total Assets
$5.5B
Debt / EquityLower = less leverage
1.29×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACHC
ACHC
KNTK
KNTK
Q1 26
$158.5M
Q4 25
$133.2M
$4.0M
Q3 25
$118.7M
$7.7M
Q2 25
$131.4M
$10.7M
Q1 25
$91.2M
$8.8M
Q4 24
$76.3M
$3.6M
Q3 24
$82.1M
$20.4M
Q2 24
$77.2M
$12.5M
Total Debt
ACHC
ACHC
KNTK
KNTK
Q1 26
$2.5B
$187.1M
Q4 25
$2.5B
$3.6B
Q3 25
$2.3B
$4.0B
Q2 25
$2.3B
$3.7B
Q1 25
$2.2B
$3.6B
Q4 24
$2.0B
$3.4B
Q3 24
$1.9B
$3.3B
Q2 24
$1.8B
$3.3B
Stockholders' Equity
ACHC
ACHC
KNTK
KNTK
Q1 26
$2.0B
Q4 25
$1.9B
$-565.4M
Q3 25
$3.1B
$-1.8B
Q2 25
$3.1B
$-1.6B
Q1 25
$3.0B
$-2.5B
Q4 24
$3.1B
$-3.0B
Q3 24
$3.0B
$-1.7B
Q2 24
$3.0B
$-1.2B
Total Assets
ACHC
ACHC
KNTK
KNTK
Q1 26
$5.5B
Q4 25
$5.5B
$7.1B
Q3 25
$6.4B
$7.2B
Q2 25
$6.3B
$7.2B
Q1 25
$6.1B
$7.0B
Q4 24
$6.0B
$6.8B
Q3 24
$5.9B
$6.9B
Q2 24
$5.7B
$6.9B
Debt / Equity
ACHC
ACHC
KNTK
KNTK
Q1 26
1.29×
Q4 25
1.28×
Q3 25
0.74×
Q2 25
0.74×
Q1 25
0.72×
Q4 24
0.64×
Q3 24
0.62×
Q2 24
0.62×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACHC
ACHC
KNTK
KNTK
Operating Cash FlowLast quarter
$61.5M
$185.1M
Free Cash FlowOCF − Capex
$101.4M
FCF MarginFCF / Revenue
24.7%
Capex IntensityCapex / Revenue
22.3%
Cash ConversionOCF / Net Profit
13.78×
TTM Free Cash FlowTrailing 4 quarters
$110.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACHC
ACHC
KNTK
KNTK
Q1 26
$61.5M
$185.1M
Q4 25
$-86.3M
$110.1M
Q3 25
$73.2M
$188.1M
Q2 25
$133.5M
$129.1M
Q1 25
$11.5M
$176.8M
Q4 24
$116.7M
$144.0M
Q3 24
$163.1M
$214.1M
Q2 24
$171.1M
$125.5M
Free Cash Flow
ACHC
ACHC
KNTK
KNTK
Q1 26
$101.4M
Q4 25
$-179.5M
$-24.0M
Q3 25
$-63.0M
$31.6M
Q2 25
$-34.2M
$1.8M
Q1 25
$-163.2M
$102.3M
Q4 24
$-86.8M
$36.3M
Q3 24
$-27.1M
$155.7M
Q2 24
$16.9M
$86.1M
FCF Margin
ACHC
ACHC
KNTK
KNTK
Q1 26
24.7%
Q4 25
-21.8%
-5.6%
Q3 25
-7.4%
6.8%
Q2 25
-3.9%
0.4%
Q1 25
-21.2%
23.1%
Q4 24
-11.2%
9.4%
Q3 24
-3.3%
39.3%
Q2 24
2.1%
24.0%
Capex Intensity
ACHC
ACHC
KNTK
KNTK
Q1 26
22.3%
Q4 25
11.3%
31.2%
Q3 25
16.0%
33.7%
Q2 25
19.3%
29.8%
Q1 25
22.7%
16.8%
Q4 24
26.3%
27.9%
Q3 24
23.3%
14.7%
Q2 24
19.4%
11.0%
Cash Conversion
ACHC
ACHC
KNTK
KNTK
Q1 26
13.78×
Q4 25
0.26×
Q3 25
2.02×
35.73×
Q2 25
4.43×
5.46×
Q1 25
1.37×
9.18×
Q4 24
3.58×
8.88×
Q3 24
2.39×
8.31×
Q2 24
2.18×
3.37×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACHC
ACHC

Acute Inpatient Psychiatric Facilities$471.0M57%
Other$140.0M17%
Specialty Treatment Facilities$128.0M15%
Residential Treatment Facilities$90.0M11%

KNTK
KNTK

Product revenue$312.2M76%
Service revenue$93.8M23%
Other revenue$4.0M1%

Related Comparisons